PER 0.00% 8.1¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-6

  1. 11,063 Posts.
    lightbulb Created with Sketch. 993
    Although it is written that past performance is not a true indicator of future performance....
    life would be so simple if it was.

    Good fortune all holders
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $61.91K 766.3K

Buyers (Bids)

No. Vol. Price($)
4 549730 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 94626 1
View Market Depth
Last trade - 15.59pm 31/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.